Results 21 to 30 of about 2,545,005 (248)

Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia [PDF]

open access: yes, 2022
[EN]In patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (ICD), catheter ablation and antiarrhythmic drugs (AADs) reduce ICD shocks, but the most effective approach remains uncertain.
Fernández-Avilés, Francisco J.   +24 more
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice

open access: yesРациональная фармакотерапия в кардиологии, 2022
Heart rhythm disorders are one of the most urgent problems in cardiology. The first reports on the possibility of using drugs in the treatment of cardiac arrhythmias began to appear in the scientific literature from the middle of the 18th century.
V. L. Doshchitsin, A. I. Tarzimanova
doaj   +1 more source

Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy. [PDF]

open access: yes, 2011
The implantable cardioverter-defibrillator (ICD) is the standard of care in patients with ischemic and nonischemic cardiomyopathy who are at high risk for arrhythmic events and sudden cardiac death.
Christopher Droogan   +7 more
core   +1 more source

COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. Comparative study of amiodarone and bisoprolol efficacy in patients with ventricular arrhythmia and metabolic syndrome.Methods. 146 patients with the AHA/NHLBI 2005 metabolic syndrome and symptomatic ventricular arrhythmia were included in the study.
V. M. Provotorov, M. L. Gluhovsky
doaj   +3 more sources

Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia

open access: yes, 2023
Atrioventricular reentrant tachycardia (AVRT) is the most common form of supraventricular tachycardia in newborns. AVRT is sometimes refractory to conventional antiarrhythmic therapy.
Romeo, Emanuele   +8 more
core   +1 more source

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010? [PDF]

open access: yesJournal of Tehran University Heart Center, 2010
Atrial fibrillation (AF) is a commonly encountered arrhythmia in our daily practice. Every year a huge bulk of data is published about different management strategies, new antiarrhythmic drugs, anticoagulation protocols and ablation procedures in these ...
Mehdi Montazeri, Gholamreza Davoodi
doaj   +2 more sources

Antiarrhythmic Medication in Neonates and Infants with Supraventricular Tachycardia [PDF]

open access: yes, 2022
Supraventricular tachycardia (SVT) is the most common arrhythmia in neonates and infants, and pharmacological therapy is recommended to prevent recurrent episodes. This retrospective study aims to describe and analyze the practice patterns, effectiveness,
Weber, Roland; https://orcid.org/   +12 more
core   +1 more source

Antiarrhythmic drug therapy prior to AF ablation.

open access: yes, 2018
Antiarrhythmic drug therapy prior to AF ablation.
Rita Riedlbauer (6061223)   +10 more
core   +1 more source

Comparison of Circumferential Pulmonary Vein Isolation and Antiarrhythmic Drug Therapy in Patients with Atrial Fibrillation [PDF]

open access: yes, 2012
The Author(s) 2012. This article is published with open access at Springerlink.com Introduction: The aim of this study was to evaluate quality of life after circumferential pulmonary vein isolation (CPVI) compared with antiarrhythmic drug therapy (ADT ...
Fawang Du   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy